Research and Markets: Liver Cancer Treatment Drugs Markets in China

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/mdj699/liver_cancer) has announced the addition of the "Liver Cancer Treatment Drugs Markets in China" report to their offering.

China's demand for Liver Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (2003, 2008 and 2013) and long-term forecasts through 2018 and 2023 are presented.

Major producers in China are profiled. A selection of these companies can be seen in the 'Companies Mentioned' tab. The full list can be viewed upon purchase of the report.

Key Topics Covered:

I. INTRODUCTION

II. BUSINESS ENVIRONMENT

III. LIVER CANCER TREATMENT DRUGS INDUSTRY ASSESSMENTS

Liver Cancer Treatment Drugs Industry Structure

Market Size

Market Growth Drivers

Liver Cancer Treatment Drugs Sales Volume

Major Producer Facility Locations

Major Producers' Sales Volume and Market Share

Labor Cost

Potential Entrants

Major Distributors

Major Foreign Investment

Technology Development

IV. LIVER CANCER TREATMENT DRUGS PRODUCTION AND DEMAND

V. LIVER CANCER TREATMENT DRUGS MARKET OUTLOOK

Liver Cancer Treatment Drugs Markets Outlook Overview

Government Regulation

Health Care Insurance Industry Overview

Consumer Spending Trends

Demographic Trends

Health Care Industry Trends

Hospitals and Hospital Beds

Physicians and Physician Visits

VI. MARKETING STRATEGIES

China Market Entry Overview

China's Distribution System

Liver Cancer Treatment Drugs Distribution Channels

Transportation and Freight Infrastructure

Communications

China's Market Entry

Licensing

Franchising

E-commerce

Trading Companies and Local Agents

Representative Offices and Chinese Subsidiaries

Wholly Foreign Owned Enterprise

VII. LIVER CANCER TREATMENT DRUGS PRODUCER DIRECTORY

Profiles of Liver Cancer Treatment Drugs Producers

Paclitaxel Producer

Docetaxel Producer

Camptotheca Alkaline

Gemcitabine Producer

Ifosfamide Producer

Cisplatin and Carboplatin Producer

Pirarubicin Producer

Mitomycin Producer

Fluorouracil Producer

Tamoxifen Producer

Triptorelin Producer

Oxaliplatin Producer

Interferon Producer

IL-2 Producer

Group A Streptococcus and Bacillus Chalmette-Guerin Producer

Companies Mentioned:

  • Lilly Pharmaceutical China
  • Hainan Haiyao

For more information visit http://www.researchandmarkets.com/research/mdj699/liver_cancer

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology